U.S.
Robert Half Up 22% Against a Falling Market: What the Q3 Filing Shows
On Oct. 23, 2026, Robert Half rose on an earnings 8-K, Genmab on a reported Phase 3 result and Netskope with its sector. Only Robert Half's move has a filing behind it.